PD-L1/PD-1 Inhibitors Plus Chemotherapy Versus Chemotherapy Alone for the Neoadjuvant Treatment of Limited-stage SCLC
Clinical trial NCT06375109 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06375109
- Sponsor
- Beijing Chest Hospital, Capital Medical University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-16
- Primary completion
- 2027-04-15
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.